Increase in head and neck cancer in younger patients due to human papillomavirus (HPV)

David Young, Christopher C. Xiao, Benjamin Murphy, Michael Moore, Carole Fakhry, Terry A. Day

Research output: Contribution to journalReview article

91 Citations (Scopus)

Abstract

The face of head and neck cancer has changed dramatically over the past 30 years. There has been a steady decline in the number of tobacco and alcohol related squamous cell carcinomas over the past 30 years, but and increasing incidence of human papillomavirus (HPV) related cancers. Some estimates suggest that 70-90% of new oropharyngeal cancers have evidence of HPV. These patients have different demographic patterns, in that they are more likely to be younger, white adults in their 40 s and 50 s who are never smokers or have reduced tobacco exposure. Studies have shown that a higher number of lifetime oral sex partners (>5) and a higher number of lifetime vaginal sex partners (>25) have been associated with increased risk of HPV positive head and neck cancer. People can also reduce their risk of HPV linked head and neck cancer by receiving the HPV vaccine series prior to becoming sexually active. Recent evidence suggests HPV related head and neck cancers present with different symptoms than those caused by tobacco. The most popular test for HPV status is the p16 immunohistochemical stain because it is cheap, simple, and studies have shown it to have comparable sensitivity and specificity to the previous standards. It is widely recommended that all cancers of the oropharynx be tested for the presence of HPV, and some recommend it for all head and neck cancers. Overall 2-year and 5-year survival for HPV positive head and neck cancer is significantly greater than for HPV negative cancers, likely due to HPV positive cancers being more responsive to treatment.

Original languageEnglish (US)
Pages (from-to)727-730
Number of pages4
JournalOral Oncology
Volume51
Issue number8
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Head and Neck Neoplasms
Oropharyngeal Neoplasms
Tobacco
Papillomavirus Vaccines
Neoplasms
Sexual Behavior
Young Adult
Squamous Cell Carcinoma
Coloring Agents
Alcohols
Demography
Sensitivity and Specificity
Survival
Incidence

Keywords

  • Head and neck cancer
  • HPV
  • HPV vaccine
  • Human papillomavirus
  • Oropharyngeal cancer
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Oral Surgery
  • Oncology
  • Cancer Research

Cite this

Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). / Young, David; Xiao, Christopher C.; Murphy, Benjamin; Moore, Michael; Fakhry, Carole; Day, Terry A.

In: Oral Oncology, Vol. 51, No. 8, 01.01.2015, p. 727-730.

Research output: Contribution to journalReview article

Young, David ; Xiao, Christopher C. ; Murphy, Benjamin ; Moore, Michael ; Fakhry, Carole ; Day, Terry A. / Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). In: Oral Oncology. 2015 ; Vol. 51, No. 8. pp. 727-730.
@article{7512f34253ca447a8f6008bdcfd09895,
title = "Increase in head and neck cancer in younger patients due to human papillomavirus (HPV)",
abstract = "The face of head and neck cancer has changed dramatically over the past 30 years. There has been a steady decline in the number of tobacco and alcohol related squamous cell carcinomas over the past 30 years, but and increasing incidence of human papillomavirus (HPV) related cancers. Some estimates suggest that 70-90{\%} of new oropharyngeal cancers have evidence of HPV. These patients have different demographic patterns, in that they are more likely to be younger, white adults in their 40 s and 50 s who are never smokers or have reduced tobacco exposure. Studies have shown that a higher number of lifetime oral sex partners (>5) and a higher number of lifetime vaginal sex partners (>25) have been associated with increased risk of HPV positive head and neck cancer. People can also reduce their risk of HPV linked head and neck cancer by receiving the HPV vaccine series prior to becoming sexually active. Recent evidence suggests HPV related head and neck cancers present with different symptoms than those caused by tobacco. The most popular test for HPV status is the p16 immunohistochemical stain because it is cheap, simple, and studies have shown it to have comparable sensitivity and specificity to the previous standards. It is widely recommended that all cancers of the oropharynx be tested for the presence of HPV, and some recommend it for all head and neck cancers. Overall 2-year and 5-year survival for HPV positive head and neck cancer is significantly greater than for HPV negative cancers, likely due to HPV positive cancers being more responsive to treatment.",
keywords = "Head and neck cancer, HPV, HPV vaccine, Human papillomavirus, Oropharyngeal cancer, Squamous cell carcinoma",
author = "David Young and Xiao, {Christopher C.} and Benjamin Murphy and Michael Moore and Carole Fakhry and Day, {Terry A.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.oraloncology.2015.03.015",
language = "English (US)",
volume = "51",
pages = "727--730",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Increase in head and neck cancer in younger patients due to human papillomavirus (HPV)

AU - Young, David

AU - Xiao, Christopher C.

AU - Murphy, Benjamin

AU - Moore, Michael

AU - Fakhry, Carole

AU - Day, Terry A.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The face of head and neck cancer has changed dramatically over the past 30 years. There has been a steady decline in the number of tobacco and alcohol related squamous cell carcinomas over the past 30 years, but and increasing incidence of human papillomavirus (HPV) related cancers. Some estimates suggest that 70-90% of new oropharyngeal cancers have evidence of HPV. These patients have different demographic patterns, in that they are more likely to be younger, white adults in their 40 s and 50 s who are never smokers or have reduced tobacco exposure. Studies have shown that a higher number of lifetime oral sex partners (>5) and a higher number of lifetime vaginal sex partners (>25) have been associated with increased risk of HPV positive head and neck cancer. People can also reduce their risk of HPV linked head and neck cancer by receiving the HPV vaccine series prior to becoming sexually active. Recent evidence suggests HPV related head and neck cancers present with different symptoms than those caused by tobacco. The most popular test for HPV status is the p16 immunohistochemical stain because it is cheap, simple, and studies have shown it to have comparable sensitivity and specificity to the previous standards. It is widely recommended that all cancers of the oropharynx be tested for the presence of HPV, and some recommend it for all head and neck cancers. Overall 2-year and 5-year survival for HPV positive head and neck cancer is significantly greater than for HPV negative cancers, likely due to HPV positive cancers being more responsive to treatment.

AB - The face of head and neck cancer has changed dramatically over the past 30 years. There has been a steady decline in the number of tobacco and alcohol related squamous cell carcinomas over the past 30 years, but and increasing incidence of human papillomavirus (HPV) related cancers. Some estimates suggest that 70-90% of new oropharyngeal cancers have evidence of HPV. These patients have different demographic patterns, in that they are more likely to be younger, white adults in their 40 s and 50 s who are never smokers or have reduced tobacco exposure. Studies have shown that a higher number of lifetime oral sex partners (>5) and a higher number of lifetime vaginal sex partners (>25) have been associated with increased risk of HPV positive head and neck cancer. People can also reduce their risk of HPV linked head and neck cancer by receiving the HPV vaccine series prior to becoming sexually active. Recent evidence suggests HPV related head and neck cancers present with different symptoms than those caused by tobacco. The most popular test for HPV status is the p16 immunohistochemical stain because it is cheap, simple, and studies have shown it to have comparable sensitivity and specificity to the previous standards. It is widely recommended that all cancers of the oropharynx be tested for the presence of HPV, and some recommend it for all head and neck cancers. Overall 2-year and 5-year survival for HPV positive head and neck cancer is significantly greater than for HPV negative cancers, likely due to HPV positive cancers being more responsive to treatment.

KW - Head and neck cancer

KW - HPV

KW - HPV vaccine

KW - Human papillomavirus

KW - Oropharyngeal cancer

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84942830139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942830139&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2015.03.015

DO - 10.1016/j.oraloncology.2015.03.015

M3 - Review article

C2 - 26066977

AN - SCOPUS:84942830139

VL - 51

SP - 727

EP - 730

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

IS - 8

ER -